标题/作者	年份
Role of hematological parameters in COVID-19 patients in the emergency room E Usul, İ Şan, B Bekgöz, A Şahin Biomarkers in Medicine 14 (13), 1207-1215	2020
Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis N Zhang, J Jiang, S Tang, G Sun International immunopharmacology 85, 106677	2020
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC) WM Brueckl, JH Ficker, G Zeitler BMC cancer 20, 1-16	2020
Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms Q Han, X Wen, L Wang, X Han, Y Shen, J Cao, Q Peng, J Xu, L Zhao, ... Journal of clinical laboratory analysis 34 (5), e23191	2020
Pretreatment neutrophil-to-lymphocyte ratio (NLR) may predict the outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) Y Li, Z Zhang, Y Hu, X Yan, Q Song, G Wang, R Chen, S Jiao, J Wang Frontiers in Oncology 10, 654	2020
EPSILoN: a prognostic score for immunotherapy in advanced non-small-cell lung cancer: a validation cohort A Prelaj, R Ferrara, SE Rebuzzi, C Proto, D Signorelli, G Galli, A De Toma, ... Cancers 11 (12), 1954	2019
Retrospective efficacy analysis of immune checkpoint inhibitor rechallenge in patients with non-small cell lung cancer Y Katayama, T Shimamoto, T Yamada, T Takeda, T Yamada, S Shiotsu, ... Journal of clinical medicine 9 (1), 102	2019
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study D Kauffmann-Guerrero, K Kahnert, R Kiefl, L Sellmer, J Walter, J Behr, ... Scientific reports 11 (1), 10919	2021
Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis H Xu, A He, A Liu, WX Tong, D Cao International immunopharmacology 77, 105957	2019
Systemic immune-inflammation index and changes of neutrophil-lymphocyte ratio as prognostic biomarkers for patients with pancreatic cancer treated with immune checkpoint blockade J Shang, X Han, H Zha, H Tao, X Li, F Yuan, G Chen, L Wang, J Ma, Y Hu Frontiers in oncology 11, 585271	2021
Peripheral blood biomarkers associated with outcome in non-small cell lung cancer patients treated with nivolumab and durvalumab monotherapy M Jiang, W Peng, X Pu, B Chen, J Li, F Xu, L Liu, L Xu, Y Xu, J Cao, ... Frontiers in Oncology 10, 913	2020
Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis A Yorulmaz, Y Hayran, U Akpinar, B Yalcin Curr Health Sci J 46 (4), 352-357	2020
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers R Lobefaro, G Viscardi, R Di Liello, G Massa, ML Iacovino, F Sparano, ... Lung Cancer 152, 165-173	2021
The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors N Liu, J Mao, P Tao, H Chi, W Jia, C Dong Medicine 101 (3)	2022
Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy C Baldessari, G Guaitoli, F Valoriani, R Bonacini, R Marcheselli, ... Clinical Nutrition ESPEN 43, 64-75	2021
The role of inflammatory indices in the outcome of COVID-19 cancer patients HA Nooh, MS Abdellateif, L Refaat, EZ Kandeel, A Bayoumi, M Samra, ... Medical Oncology 39, 1-14	2022
A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers KL Ayers, M Ma, G Debussche, D Corrigan, J McCafferty, K Lee, ... BMC cancer 21, 1-11	2021
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo-or immunotherapy RD Seban, JB Assié, E Giroux-Leprieur, MA Massiani, G Bonardel, ... Lung Cancer 159, 45-55	2021
Predictive value of systemic immune-inflammation index and neutrophil-to-lymphocyte ratio in patients with severe COVID-19 W Xia, Y Tan, S Hu, C Li, T Jiang Clinical and Applied Thrombosis/Hemostasis 28, 10760296221111391	2022
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics L Mezquita, I Preeshagul, E Auclin, D Saravia, L Hendriks, H Rizvi, ... European Journal of Cancer 151, 211-220	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。